Evidence map›Paper›PMID 31752329›Full record

ArticleInternational journal of molecular sciences2019

Predictive Value of Serum Antibodies and Point Mutations of AQP4, AQP1 and MOG in A Cohort of Spanish Patients with Neuromyelitis Optica Spectrum Disorders.

Pablo García-Miranda, Francisco J Morón-Civanto, Maria Del Mar Martínez-Olivo, Nela Suárez-Luna, Reposo Ramírez-Lorca, Lucía Lebrato-Hernández, Raquel Lamas-Pérez, Guillermo Navarro, Javier Abril-Jaramillo, Maria Isabel García-Sánchez and 5 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 1 country.

Pablo García-MirandaInstituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, 41013 Seville, Spain.
Francisco J Morón-CivantoInstituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, 41013 Seville, Spain.
Maria Del Mar Martínez-OlivoInstituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, 41013 Seville, Spain.
Nela Suárez-LunaInstituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, 41013 Seville, Spain.
Reposo Ramírez-LorcaInstituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, 41013 Seville, Spain.ORCID 0000-0002-1594-0404
Lucía Lebrato-HernándezUnidad de Gestión Clínica de Neurociencias, Servicio de Neurología del Hospital Universitario Virgen del Rocío, 41013 Sevilla, Spain.
Raquel Lamas-PérezUnidad de Gestión Clínica de Neurociencias, Servicio de Neurología del Hospital Universitario Virgen del Rocío, 41013 Sevilla, Spain.
Guillermo NavarroServicio de Neurología del Hospital Universitario Virgen Macarena, 41009 Sevilla, Spain.
Javier Abril-JaramilloServicio de Neurología del Hospital Universitario Virgen Macarena, 41009 Sevilla, Spain.
Maria Isabel García-SánchezServicio de Neurología del Hospital Universitario Virgen Macarena, 41009 Sevilla, Spain.
José Luis Casado-ChocánUnidad de Gestión Clínica de Neurociencias, Servicio de Neurología del Hospital Universitario Virgen del Rocío, 41013 Sevilla, Spain.
Antonio José Uclés-SánchezUnidad de Gestión Clínica de Neurociencias, Servicio de Neurología del Hospital Universitario Virgen del Rocío, 41013 Sevilla, Spain.
Mercedes RomeraServicio de Neurología del Hospital Universitario Virgen de Valme, 41014 Sevilla, Spain.
Miriam EchevarríaInstituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, 41013 Seville, Spain.ORCID 0000-0002-4758-9428
María Díaz-SánchezUnidad de Gestión Clínica de Neurociencias, Servicio de Neurología del Hospital Universitario Virgen del Rocío, 41013 Sevilla, Spain.
Instituto de Biomedicina de Sevilla · ESHospital Universitario Virgen del Rocío · ESHospital Universitario Virgen Macarena · ESHospital Universitario de Valme · ES

Funding

Instituto de Salud Carlos III PI16/01249 , PI16/00493
6 · The paper itself

Abstract

The detection of IgG aquaporin-4 antibodies in the serum of patients with Neuromyelitis optica (NMO) has dramatically improved the diagnosis of this disease and its distinction from multiple sclerosis. Recently, a group of patients have been described who have an NMO spectrum disorder (NMOsd) and who are seronegative for AQP4 antibodies but positive for IgG aquaporin-1 (AQP1) or myelin oligodendrocyte glycoprotein (MOG) antibodies. The purpose of this study was to determine whether AQP1 and MOG could be considered new biomarkers of this disease; and if point mutations in the gDNA of

Indexed as

AdultAntibodiesAquaporin 1Aquaporin 4BiomarkersCohort StudiesDisease ProgressionFemaleHumansMaleMiddle AgedMyelin-Oligodendrocyte GlycoproteinNeuromyelitis OpticaPoint MutationAntibodiesAQP1 protein, humanAQP4 protein, humanAquaporin 1Aquaporin 4BiomarkersMOG protein, humanMyelin-Oligodendrocyte GlycoproteinAQPsdemyelinating diseasegene sequencingimmunohistochemistryMOGNMOsd

Identifiers

PMID31752329
PMCPMC6887710
OpenAlexW2989940331

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.